164 related articles for article (PubMed ID: 22078456)
1. Developing treatment options for metachromatic leukodystrophy.
Batzios SP; Zafeiriou DI
Mol Genet Metab; 2012 Jan; 105(1):56-63. PubMed ID: 22078456
[TBL] [Abstract][Full Text] [Related]
2. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment.
van Rappard DF; Boelens JJ; Wolf NI
Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):261-73. PubMed ID: 25987178
[TBL] [Abstract][Full Text] [Related]
3. Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA; Maegawa GH
Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy in metachromatic leukodystrophy.
Sevin C; Cartier-Lacave N; Aubourg P
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
[TBL] [Abstract][Full Text] [Related]
5. Metachromatic leukodystrophy--an update.
Gieselmann V; Krägeloh-Mann I
Neuropediatrics; 2010 Feb; 41(1):1-6. PubMed ID: 20571983
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy.
Cartier N; Aubourg P
Curr Opin Mol Ther; 2008 Oct; 10(5):471-8. PubMed ID: 18830923
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for metachromatic leukodystrophy.
Rosenberg JB; Kaminsky SM; Aubourg P; Crystal RG; Sondhi D
J Neurosci Res; 2016 Nov; 94(11):1169-79. PubMed ID: 27638601
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
[TBL] [Abstract][Full Text] [Related]
11. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
Gieselmann V
Acta Paediatr; 2008 Apr; 97(457):15-21. PubMed ID: 18339182
[TBL] [Abstract][Full Text] [Related]
12. Metachromatic leukodystrophy: an overview of current and prospective treatments.
Biffi A; Lucchini G; Rovelli A; Sessa M
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S2-6. PubMed ID: 18978739
[TBL] [Abstract][Full Text] [Related]
13. Metachromatic leukodystrophy: recent research developments.
Gieselmann V
J Child Neurol; 2003 Sep; 18(9):591-4. PubMed ID: 14572136
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
[TBL] [Abstract][Full Text] [Related]
15. Genetics of metachromatic leukodystrophy.
Gieselmann V; Kreysing J; von Figura K
Gene Ther; 1994; 1 Suppl 1():S87. PubMed ID: 8542433
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy of metachromatic leukodystrophy.
Matzner U; Gieselmann V
Expert Opin Biol Ther; 2005 Jan; 5(1):55-65. PubMed ID: 15709909
[TBL] [Abstract][Full Text] [Related]
17. Atidarsagene autotemcel for metachromatic leukodystrophy.
Messina M; Gissen P
Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
[TBL] [Abstract][Full Text] [Related]
18. Novel candidate disease for gene therapy: metachromatic leukodystrophy.
Biffi A; Naldini L
Expert Opin Biol Ther; 2007 Aug; 7(8):1193-205. PubMed ID: 17696818
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
20. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.
Sevin C; Aubourg P; Cartier N
J Inherit Metab Dis; 2007 Apr; 30(2):175-83. PubMed ID: 17347913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
